# To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment

> **NCT05508438** · NA · NOT_YET_RECRUITING · sponsor: **Pan Xiangbin** · enrollment: 140 (estimated)

## Conditions studied

- Mitral Valve Insufficiency

## Interventions

- **DEVICE:** Transfemoral mitral-valve repair

## Key facts

- **NCT ID:** NCT05508438
- **Lead sponsor:** Pan Xiangbin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-08-30
- **Primary completion:** 2023-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2022-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05508438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05508438, "To Evaluate the Efficacy and Safety of the Transfemoral Mitral Valve Repair System in the Treatment of Patients With Moderately Severe and Severe Functional Mitral Regurgitation(FMR) Who Remained Clinically Symptomatic After Guideline-directed Medical Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05508438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*